Squarepoint
BVS icon

Squarepoint’s Bioventus BVS Stock Holding History

Squarepoint’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.54M Buy
269,267
+48,414
+22% +$462K ﹤0.01% 2156
2026
Q1 		$2.02M Buy
220,853
+29,680
+16% +$249K ﹤0.01% 2178
2025
Q4 		$1.42M Buy
191,173
+43,493
+29% +$313K ﹤0.01% 2318
2025
Q3 		$988K Buy
147,680
+39,628
+37% +$275K ﹤0.01% 2704
2025
Q2 		$715K Buy
108,052
+64,459
+148% +$457K ﹤0.01% 2951
2025
Q1 		$399K Buy
+43,593
New +$435K ﹤0.01% 3501
2024
Q4 		– Sell
-30,154
Closed -$360K – 5038
2024
Q3 		$360K Buy
30,154
+3,983
+15% +$34.4K ﹤0.01% 3328
2024
Q2 		$150K Buy
26,171
+3,170
+14% +$17.4K ﹤0.01% 3726
2024
Q1 		$120K Buy
+23,001
New +$112K ﹤0.01% 3764
2023
Q1 		– Sell
-65,057
Closed -$170K – 3256
2022
Q4 		$170K Buy
+65,057
New +$284K ﹤0.01% 2837
2022
Q1 		– Sell
-13,271
Closed -$192K – 2863
2021
Q4 		$192K Buy
+13,271
New +$189K ﹤0.01% 2721

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Squarepoint's BVS Position: Q2 2026 in Review

Squarepoint increased its Bioventus (BVS) stake by 22% in Q2 2026, buying an estimated $462K and bringing the position to 269,267 shares worth $2.54M. The position accounts for ﹤0.01% of the portfolio, ranked #2156.

Squarepoint first reported a position in BVS in Q4 2021 and has held it in 11 quarters since. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Squarepoint held 269,267 shares of Bioventus worth $2.54M as of Q2 2026.
  • Squarepoint bought 48,414 Bioventus shares in Q2 2026, an estimated $462K.
  • Bioventus made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2156 holding.
  • Squarepoint first reported a position in Bioventus in Q4 2021 and has held it in 11 quarters since.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.